University of California, SF J. Claude Hemphill, III, MD University of Kentucky Roger Humphries, MD University of Cincinnati Arthur Pancioli, MD University of Maryland Barney J. Stern, MD University of Minnesota Michelle Biros, MD, MS University of Pennsylvania Jill Baren, MD, MBE University of Texas Elizabeth Jones, MD Virginia Commonwealth University Joseph P. Ornato, MD Wayne State University Robert Welch, MD Emory University David Wright, MD Henry Ford Health System Christopher Lewandowski, MD Medical College of Wisconsin Tom Aufderheide, MD New York Presbyterian Hospital Stephan Mayer, MD Oregon Health & Science University Robert Lowe, MD, MPH Stanford University James V. Quinn, MD Temple University Nina Gentile, MD University of Arizona Kurt Denninghoff, MD CLINICAL COORDINATING CENTER (CCC) University of Michigan William Barsan, MD National Institute of Neurological Disorders and Stroke (NINDS) Clinical Trial Group Robin Conwit, MD and Scott Janis, PhD STATISTICAL & DATA MANAGEMENT CENTER (SDMC) Medical University of South Carolina Yuko Palesch, PhD PARTICIPATING HUBS AND INVESTIGATORS Enrollment as of 8/31/12 12:00 pm EDT ALIAS ProTECT POINT SHINE Arizona 5 50 14 Not Acve Kentucky 32 18 22 < 5 Oregon 57 24 24 Not Acve NYP 32 < 5 34 < 5 Minnesota 22 58 40 Not Acve Maryland 15 < 5 19 < 5 Henry Ford 12 11 30 Not Acve Emory 27 60 19 < 5 Cincinna 30 67 42 <5 Stanford 26 56 32 Not Acve Temple 29 39 26 < 5 Texas 36 55 33 < 5 UCSF 25 18 19 < 5 UPenn 42 40 91 < 5 VCU 11 21 12 Not Acve Wayne State 32 15 63 < 5 Wisconsin 15 62 14 < 5 Emmes (POINT only) - - 520 - Ancillary Sites (SHINE only) - - - 12 TOTAL 448 601 1054 20 *OHSU WAS AN ORIGINAL SITE IN THE ALIAS I TRIAL AND CONTINUES IN THE ALIAS II TRIAL UNDER THE SAME CONTRACTUAL ARRANGEMENT WITH THE UNIVERSITY OF MIAMI STUDY CHAIR SITE.
University of California, SFJ. Claude Hemphill, III, MD
University of KentuckyRoger Humphries, MDUniversity of Cincinnati
Arthur Pancioli, MDUniversity of Maryland
Barney J. Stern, MD University of MinnesotaMichelle Biros, MD, MS
University of PennsylvaniaJill Baren, MD, MBEUniversity of Texas
Elizabeth Jones, MDVirginia Commonwealth University
Joseph P. Ornato, MDWayne State University
Robert Welch, MD
Emory UniversityDavid Wright, MDHenry Ford Health System Christopher Lewandowski, MDMedical College of Wisconsin Tom Aufderheide, MDNew York Presbyterian HospitalStephan Mayer, MDOregon Health & Science UniversityRobert Lowe, MD, MPHStanford University James V. Quinn, MDTemple University Nina Gentile, MDUniversity of Arizona Kurt Denninghoff, MD
cliNical coordiNaTiNg cENTEr (ccc) University of MichiganWilliam Barsan, MD
National Institute of Neurological Disorders and Stroke (NINDS)
Clinical Trial GroupRobin Conwit, MD and Scott Janis, PhD
sTaTisTical & daTa maNagEmENT cENTEr (sdmc) Medical University of South Carolina
Yuko Palesch, PhD
ParTiciPaTiNg Hubs aNd iNvEsTigaTors
Enrollment as of 8/31/12 12:00 pm EDT ALIAS ProTECT POINT SHINE
*OHSU WAS AN ORIGINAL SITE IN THE ALIAS I TRIAL AND CONTINUES IN THE ALIAS II TRIAL UNDER THE SAME CONTRACTUAL ARRANGEMENT WITH THE UNIVERSITY OF MIAMI STUDY CHAIR SITE.
Pleased to meet you...Joshua Goldstein, MD, PhDNETTHubPrincipalInvestigatorMassachusettsGeneralHospitalDr. Goldstein joined the ED at Massachusetts General Hospital in 2006 after an emergency medicine residency and a research fellowship in Vascular and Critical Care Neurology. His clinical research program studies the acute diagnosis and management of patients with neurologic emergencies, including a focus on intracerebral hemorrhage. He lives north of Boston with his wife, Erica, two daughters, Alexa (11) and Lindsey (8), and their dog Bella. They love skiing, hiking, and taking bike rides. Dr. Goldstein definitely does not play violent (but awesome) videogames like Modern Warfare because that would set a terrible example for his daughters and he totally would not do that.
Bethany Lane, RNProTECT Project ManagerEmory UniversityBethany has been a clinical research nurse at Emory University since 2000. Prior to joining the NETT in July, her experience included stroke neurology research, bone marrow transplant, oncology, and management of a 4-state branch of a home infusion company. Bethany is a native of Washington state and was a West-Coaster her entire life prior to moving to Atlanta in 1995. She enjoys travel and has been in all but 2 states - Delaware and Hawaii. Bethany and her husband, Ron, are active volunteers with the Georgia Council for International Visitors and have hosted people from more than 25 countries. Bethany and Ron enjoy what they call “electric camping”. This involves a camper with electricity for air conditioning, an electric blanket, microwave, and a margarita blender - life’s little essentials.
Ben Hume, BSNETT Research AssistantUniversityofMichigan,ClinicalCoordinatingCenterBen completed his Bachelor’s degree in Chemistry this past May at Centre College in Danville, Kentucky. He worked at the Clinical Coordinating Center last summer and is glad to be back. Ben wants to become a physician and is currently in the process of applying to medical schools. In his free time, Ben likes to spend time with his family and friends, and loves sports. He was an All-American football player in college. Another love of his is travel. He has traveled the world - England, Australia, New Zealand, and Mexico just to name a few. His favorite destination so far is New Zealand and he hopes to go back someday soon.
Platelet-Oriented Inhibition in New TIA TrialPrincipal Investigator: Clay Johnston, MD
EnrollmentThe current enrollment number of 1054 puts POINT enrollment at one quarter of our target! Thank you to all of the study teams for your hard work.
• Please be sure someone is trained in the shipment of biological specimens.• Upload the certifications to WebDCU.• Add shipping to the Delegation of Authority Log.• Lab Kits will be available mid to late September. -Tess Bonham ([email protected])
POINT WebDCUThe database freeze for the DSMB meeting will occur on Tuesday, September 4, 2012. Please address any miss-ing data at your site prior to the afternoon of September 4th. -Aaron Perlmutter ([email protected])
Margie Sharpe, MA, RDProTECT Data ManagerMedical University of South CarolinaMargie graduated from Clemson University with a Master’s degree in Economics. She went on to work for a Big Four accounting firm in Atlanta as a financial analyst before returning to school to pursue a degree in Dietetics from Winthrop University. She completed the Reg-istered Dietician program at the Medical University of South Carolina this summer while also working for a physician on campus in hyper-tension research. Margie was born in Charleston and enjoys spending time outside at the beach or on the boat with her boyfriend, friends, and family, including her parents, three brothers, and sister-in-law, all of whom live close by.
ProTECT III Investigator Meeting, November 12-14, 2012, Atlanta, GA. More details to come next month. -Erin Zaleski ([email protected])
ProTECT™IIIPrincipalInvestigator:DavidWright,MD
Thank you to all of the sites for your continued commitment to SHINE. We currently have 19 sites (Hub and Spokes) that have been released to enroll and are up to 20 enrolled subjects! Congratulations to all the active sites. Keep up the great work!
SAVE THE DATE: SHINE Investigator Meeting, November 11-12, 2012, Atlanta, GA. More details to come next month.
Principal Investigators: Karen Johnston, MD, MSc, Askiel Bruno, MD, and Christiana Hall, MD
WebDCU™:
Reminder for Changes to Study Team MembersWhen a study team member at your spoke is no longer working on a trial or becomes a study team member at an additional spoke, please notify the data manager for that trial to update that person’s WebDCU™ permissions. The ‘Is Active’ status in the [Project Spoke Team Member Table] refers to someone’s status as an active/inactive study team member, not whether or not that person has an active/inactive WebDCU™ account. It is critical that database permissions be created for study team members at all spokes where they participate to avoid random-ization problems.
